A detailed history of Premier Path Wealth Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 4,274 shares of EW stock, worth $281,400. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,274
Previous 5,530 22.71%
Holding current value
$281,400
Previous $511 Million 44.79%
% of portfolio
0.04%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$59.7 - $93.78 $74,983 - $117,787
-1,256 Reduced 22.71%
4,274 $282 Million
Q2 2024

Jul 24, 2024

BUY
$84.3 - $94.31 $61,201 - $68,469
726 Added 15.11%
5,530 $511 Million
Q1 2024

Apr 24, 2024

BUY
$72.54 - $95.56 $72 - $95
1 Added 0.02%
4,804 $459 Million
Q4 2023

Jan 12, 2024

BUY
$61.71 - $77.76 $296,393 - $373,481
4,803 New
4,803 $366 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Premier Path Wealth Partners, LLC Portfolio

Follow Premier Path Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Path Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Path Wealth Partners, LLC with notifications on news.